{
    "nctId": "NCT04568161",
    "briefTitle": "Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses",
    "officialTitle": "Chronic Effect of Doxorubicin and Cyclophosphamide on Neurovascular Control and Blood Pressure in Women in Adjuvant Treatment for Breast Neoplasia",
    "overallStatus": "RECRUITING",
    "conditions": "Cardiotoxicity, Cardiovascular Disease, Neurovascular Disorder, Endothelial Disfunction, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 15,
    "primaryOutcomeMeasure": "Muscle sympathetic nerve activity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosis of stage II-III breast cancer\n* starting adjuvant chemotherapy\n\nExclusion Criteria:\n\n* metastatic disease,\n* hypercholesterolemia, diabetes,\n* hypertension,\n* severe lymphedema,\n* organic disorders (renal failure, heart failure and chronic liver disease),\n* obesity (BMI\\> 30) and,\n* who are under pharmacological treatment with statins, angiotensin-converting enzyme inhibitors, losartan potassium, beta blockers or antioxidants",
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "stdAges": "ADULT"
}